SNY - The Medicines Company: Impact Of Inclisiran Pricing On Stock Value
Valuing a pharmaceutical company stock like The Medicine Company (MDCO) requires knowledge of clinical trial stages, success rates within peer groups, drug substitutes, patent expiration timeframes, and ideally a medical background that allows analysis of the ongoing clinical trials involved. That comes on top of estimating addressable market, sales, expenses, debt structure, cash flow, growth rate, and more. To break down the vast scope of fundamental analysis of the Medicines Company into several parts, in this article, I’d like to focus on the projected company revenue and profitability and implications of pricing their